However, in Gram negative bacterial activity all derivatives besides 23, 25 and 27 were found to be potent against Salmonella paratyphi A, Salmonella paratyphi B, Shigella dysenteriae
, and Shigella flexnerii than against Escherichia coli multidrug resistance and Pseudomonas aeruginosa ATCC, while compound 20 was found to be most active than rest of the compounds against S.
Molecular characterization of the SHV-11 Beta lactamase of Shigella dysenteriae
Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae
serotype 1 clinical isolates from Kolkata, India.
Bacterial species such as, Escherchia coli, Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Shigella dysenteriae
, Clostridium sporogenes, and Salmonella parathypi A were obtained from the laboratory of Biopharma, The Vaccine Manufacture, Bandung, Indonesia.
1) These virulence factors are mainly produced by Shigella dysenteriae
and Shigatoxigenic group of Escherichia coli like E.
Temporal shifts in the dominance of serotypes of Shigella dysenteriae
from 1999 to 2002 in Dhaka Bangladesh.
, once the most common species causing severe disease, has been replaced by Shigella flexneri in most of the countries (1).
es reconocida en producir brotes esporadicos o epidemicos alrededor del mundo (6-10).
Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae
They were: Bacillus cereus, Bacillus megaterium, Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella paratyphi, Salmonella typhi, Shigella dysenteriae
, Shigella sonnei, and Vibrio cholerae.
This is notably the case in Bordetella avium (1), Clostridium botulinum (2), Corynebacterium diphtheriae (3), Escherichia coli (4), Pseudomonas aeruginosa (5), Shigella dysenteriae
(6), Staphylococcus aureus (7) and Streptococcus pyogenes (8).
M2 PHARMA-October 8, 2010-GlycoVaxyn completes Phase I trial of Shigella dysenteriae
vaccine(C)2010 M2 COMMUNICATIONS